斑点征与弥漫征:双能CT颅内血肿扩大的定量标志物
本回顾性研究纳入42例颅内出血患者,采用双能CT碘定量结合机器学习(朴素贝叶斯分类器)识别血肿扩大的碘外渗标志物,并在65例新患者中独立验证。基于血肿总碘浓度(Ih)和最亮点灶性碘浓度(Ibs)构建的I2评分以20为最佳分类阈值,训练集准确率85%、敏感度79%、特异度88%,验证集准确率89%、敏感度71%、特异度93%,均优于常规斑点征。
要点
- 双能CT碘定量可提取血肿总碘浓度(Ih)与最亮点灶性碘浓度(Ibs)两个预测血肿扩大的定量标志物。
- I2评分最佳分类阈值为20,验证集敏感度71%、特异度93%,高于常规斑点征的57%和83%。
- I2评分用于高敏感度风险评估,体现双能CT碘含量测量的临床价值。
核心结论
- 本研究在脑双能CT上识别出两个颅内血肿扩大的定量标志物,由其衍生的I2评分凸显了双能CT碘含量测量用于高敏感度风险评估的效用。
研究设计与样本
- 回顾性研究,训练集42例(平均年龄66岁±15,19名女性),2014年10月至2017年1月因颅内出血转诊行双能CT评估;采用机器学习方法(朴素贝叶斯分类器)识别外渗的碘标志物;验证集为2017年2月至2018年2月的65例新患者。
诊断标准与关键数值
- 双能CT图像分析识别出两个碘外渗特征:血肿内总碘浓度(Ih)与血肿最亮点灶性碘浓度(Ibs),由其衍生I2评分衡量扩大概率;最佳分类阈值为I2评分20(95%CI:18,23);训练集正确识别46例血肿中的39例(85%;95%CI:71%,94%),敏感度79%(11/14;95%CI:57%,100%),特异度88%(28/32;95%CI:76%,99%);验证集正确识别70例血肿中的62例(89%;95%CI:79%,95%),敏感度71%(10/14;95%CI:48%,95%),特异度93%(52/56;95%CI:86%,100%);常规斑点征训练集敏感度57%(8/14)、特异度90%(29/32)、准确率80%(37/46),验证集敏感度57%(8/14)、特异度83%(47/56)、准确率75%(53/70)。
临床应用与阅片要点
- 作者指出,由双能CT碘定量标志物衍生的I2评分凸显了双能CT碘含量测量用于高敏感度风险评估的效用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To compare dual-energy CT with iodine quantification to single-energy CT for evaluation of the spot sign for intracranial hematoma expansion. Materials and Methods In this retrospective study, 42 patients (mean age, 66 years ± 15 [standard deviation]; 19 women) were referred for dual-energy CT assessment of intracranial hemorrhage from October 2014 to January 2017. A machine learning approach (naive Bayes classifier) was used to identify iodine markers of extravasation for risk of hematoma expansion. Specificity and sensitivity of these markers were then independently validated in 65 new patients from February 2017 to February 2018. Results Analysis of dual-energy CT images identified two features of iodine extravasation: total iodine concentration within the hematoma (Ih) and focal iodine concentration in the brightest spot in the hematoma (Ibs) as predictors of expansion. The I2 score derived from these features provided a measure of expansion probability. Optimal classification threshold was an I2 score of 20 (95% confidence interval [CI]: 18, 23), leading to correct identification of 39 of 46 (85%; 95% CI: 71%, 94%) of the hematomas on the training set (sensitivity of 79% [11 of 14; 95% CI: 57%, 100%] and specificity of 88% [28 of 32; 95% CI: 76%, 99%]), and 62 of 70 (89%; 95% CI: 79%, 95%) of the hematomas on the validation set (sensitivity of 71% [10 of 14; 95% CI: 48%, 95%] and specificity of 93% [52 of 56; 95% CI: 86%, 100%]). Sensitivity, specificity, and accuracy of conventional spot sign were, respectively, 57% (eight of 14), 90% (29 of 32), and 80% (37 of 46) on the training set and 57% (eight of 14), 83% (47 of 56), and 75% (53 of 70) on the validation set. Conclusion This study identified two quantitative markers of intracranial hemorrhage expansion at dual-energy CT of the brain. The I2 score derived from these markers highlights the utility of dual-energy CT measurements of iodine content for high sensitivity risk assessment. © RSNA, 2018 Online supplemental material is available for this article.
引用
- Tan CO, Lam S, Kuppens D, et al. Spot and Diffuse Signs: Quantitative Markers of Intracranial Hematoma Expansion at Dual-Energy CT. Radiology. 2018. PMID: 30375929. doi:10.1148/radiol.2018180322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。